Cite

    Kato, M. et al. (2021). Dramatic, significant metabolic response to a one‐time pembrolizumab treatment following a relapse of pre‐existing organizing pneumonia in a patient with advanced non‐small cell lung cancer: A case report. Thoracic cancer. 12 (22), pp. 3076-3079. [Online].